Literature DB >> 25711999

Antidote shortages in the USA: impact and response.

.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25711999      PMCID： PMC4371016          DOI： 10.1007/s13181-013-0372-1

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  11 in total

1.  Survey of the stocking of poison antidotes in Alabama hospitals.

Authors:  W M Teresi; W D King
Journal:  South Med J       Date:  1999-12       Impact factor: 0.954

2.  Emergency department preparedness for the evaluation and treatment of victims of biological or chemical terrorist attack.

Authors:  Michael I Greenberg; Sherri M Jurgens; Ed J Gracely
Journal:  J Emerg Med       Date:  2002-04       Impact factor: 1.484

3.  Lack of hospital preparedness for chemical terrorism in a major US city: 1996-2000.

Authors:  Mark E Keim; Nicki Pesik; Nana A Y Twum-Danso
Journal:  Prehosp Disaster Med       Date:  2003 Jul-Sep       Impact factor: 2.040

4.  Inadequate pyridoxine stock and its effect on patient outcome.

Authors:  Anthony M Burda; Todd Sigg; Danish Haque; Christina Hantsch Bardsley
Journal:  Am J Ther       Date:  2007 May-Jun       Impact factor: 2.688

5.  Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care.

Authors:  Richard C Dart; Stephen W Borron; E Martin Caravati; Daniel J Cobaugh; Steven C Curry; Jay L Falk; Lewis Goldfrank; Susan E Gorman; Stephen Groft; Kennon Heard; Ken Miller; Kent R Olson; Gerald O'Malley; Donna Seger; Steven A Seifert; Marco L A Sivilotti; Tammi Schaeffer; Anthony J Tomassoni; Robert Wise; Gregory M Bogdan; Mohammed Alhelail; Jennie Buchanan; Jason Hoppe; Eric Lavonas; Sara Mlynarchek; Dong-Haur Phua; Sean Rhyee; Shawn Varney; Amy Zosel
Journal:  Ann Emerg Med       Date:  2009-05-05       Impact factor: 5.721

6.  Insufficient stocking of poisoning antidotes in hospital pharmacies.

Authors:  R C Dart; Y Stark; B Fulton; J Koziol-McLain; S R Lowenstein
Journal:  JAMA       Date:  1996-11-13       Impact factor: 56.272

7.  On-site availability of selected antidotes: results of a survey of Massachusetts hospitals.

Authors:  A D Woolf; K Chrisanthus
Journal:  Am J Emerg Med       Date:  1997-01       Impact factor: 2.469

Review 8.  Antidotes for toxicological emergencies: a practical review.

Authors:  Jeanna M Marraffa; Victor Cohen; Mary Ann Howland
Journal:  Am J Health Syst Pharm       Date:  2012-02-01       Impact factor: 2.637

9.  Acute isoniazid toxicity and the need for adequate pyridoxine supplies.

Authors:  Lee E Morrow; Robert E Wear; Dan Schuller; Mark Malesker
Journal:  Pharmacotherapy       Date:  2006-10       Impact factor: 4.705

10.  Preparing for chemical terrorism: a study of the stability of expired pralidoxime (2-PAM).

Authors:  Robert S Hoffman; Maria Mercurio-Zappala; Nicole Bouchard; Padinjarekuttu Ravikumar; Lewis Goldfrank
Journal:  Disaster Med Public Health Prep       Date:  2011-11-28       Impact factor: 1.385
View more
  4 in total

1.  ACMT Position Statement: Alternative or Contingency Countermeasures for Acetylcholinesterase Inhibiting Agents.

Authors:  Andrew Stolbach; Vikhyat Bebarta; Michael Beuhler; Shaun Carstairs; Lewis Nelson; Michael Wahl; Paul M Wax; Charles McKay
Journal:  J Med Toxicol       Date:  2018-04-17

2.  Management of Lead Encephalopathy with DMSA After Exposure to Lead-Contaminated Moonshine.

Authors:  Justin Arnold; Brent Morgan
Journal:  J Med Toxicol       Date:  2015-12

3.  Taking stock: UK national antidote availability increasing, but further improvements are required.

Authors:  G P Bailey; B Rehman; K Wind; D M Wood; R Thanacoody; S Nash; Jrh Archer; M Eddleston; J P Thompson; J A Vale; Shl Thomas; P I Dargan
Journal:  Eur J Hosp Pharm       Date:  2015-11-18

Review 4.  The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.

Authors:  Harry F Williams; Harry J Layfield; Thomas Vallance; Ketan Patel; Andrew B Bicknell; Steven A Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2019-06-20       Impact factor: 4.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.